Arbutus Biopharma Corp (ABUS) Stock to return to profitability in the near future

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

Arbutus Biopharma Corp (NASDAQ:ABUS) Stock Price Settled at $2.36: What’s Resulting?

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

A fresh round of sideways trading continues for Arbutus Biopharma Corp (ABUS) Stock.

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]